Showing results (1071-1080 of 12,169) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|September 1, 1992
Mechanism of halothane attenuation of isometric tension induced by serotonin in isolated canine coronary artery ringsG Blaise, L Dumont, J Buluran, et al.Journal of Cardiovascular Pharmacology|September 1, 1992
Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dogG Duker, O Almgren, L CarlssonJournal of Cardiovascular Pharmacology|September 1, 1992
Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusionE Riva, M Kurosaki, R LatiniJournal of Cardiovascular Pharmacology|September 1, 1992
The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive ratsA Monopoli, E Ongini, E Cigola, et al.Journal of Cardiovascular Pharmacology|September 1, 1992
Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjectsW J Louis, B S Workman, E L Conway, et al.Journal of Cardiovascular Pharmacology|January 1, 1992
How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the noninvasive approachD Andresen, S Behrens, R Stern, et al.Journal of Cardiovascular Pharmacology|January 1, 1992
How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approachM Borggrefe, W Haverkamp, M Shenasa, et al.Journal of Cardiovascular Pharmacology|January 1, 1992
The utility of serum drug level monitoring during therapy with class III antiarrhythmic agentsF FollathJournal of Cardiovascular Pharmacology|January 1, 1992
Differential analysis of frequency-dependent effects of antiarrhythmic drugs: importance of the saturation behavior of frequency-dependent sodium-channel blockadeJ Weirich, S Hohnloser, H AntoniJournal of Cardiovascular Pharmacology|January 1, 1992
Dofetilide, a novel class III antiarrhythmic agentH S Rasmussen, M J Allen, K J Blackburn, et al.Pageof 1,217